Myocarditis with COVID-19 mRNA vaccines

B Bozkurt, I Kamat, PJ Hotez - Circulation, 2021 - Am Heart Assoc
Myocarditis has been recognized as a rare complication of coronavirus disease 2019
(COVID-19) mRNA vaccinations, especially in young adult and adolescent males. According …

Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series

A Fazlollahi, M Zahmatyar, M Noori… - Reviews in medical …, 2022 - Wiley Online Library
There have been several local and systemic adverse events associated with mRNA COVID‐
19 vaccines. Pericarditis, myocarditis and myocardial infarction are examples of cardiac …

Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021

ME Oster, DK Shay, JR Su, J Gee, CB Creech… - Jama, 2022 - jamanetwork.com
Importance Vaccination against COVID-19 provides clear public health benefits, but
vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID …

[HTML][HTML] Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting

N Barda, N Dagan, Y Ben-Shlomo… - … England Journal of …, 2021 - Mass Medical Soc
Background Preapproval trials showed that messenger RNA (mRNA)–based vaccines
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety …

Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination

DT Truong, A Dionne, JC Muniz, KE McHugh… - Circulation, 2022 - Am Heart Assoc
Background: Understanding the clinical course and short-term outcomes of suspected
myocarditis after the coronavirus disease 2019 (COVID-19) vaccination has important public …

Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination

GT Chua, MYW Kwan, CSL Chui… - Clinical Infectious …, 2022 - academic.oup.com
Background Age-specific incidence of acute myocarditis/pericarditis in adolescents following
Comirnaty vaccination in Asia is lacking. This study aimed to study the clinical characteristics …

Carditis after COVID-19 vaccination with a messenger RNA vaccine and an inactivated virus vaccine: a case–control study

FTT Lai, X Li, K Peng, L Huang, P Ip, X Tong… - Annals of internal …, 2022 - acpjournals.org
Background: Case reports of carditis after BNT162b2 vaccination are accruing worldwide.
Objective: To examine the association of BNT162b2 and CoronaVac (Sinovac) vaccination …

[HTML][HTML] COVID-19 mRNA vaccination leading to CNS inflammation: a case series

M Khayat-Khoei, S Bhattacharyya, J Katz… - Journal of …, 2022 - Springer
The availability of vaccines against the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID …

[HTML][HTML] SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

A Husby, JV Hansen, E Fosbøl, EM Thiesson… - bmj, 2021 - bmj.com
Objective To investigate the association between SARS-CoV-2 vaccination and myocarditis
or myopericarditis. Design Population based cohort study. Setting Denmark. Participants 4 …

Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung

S Vygen-Bonnet, J Koch, C Bogdan, T Harder… - 2021 - edoc.rki.de
Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …